Corcept Therapeutics Incorporated announced the appointment, effective August 16, 2021, of William Guyer, PharmD, as the company’s Chief Development Officer. Dr. Guyer comes to Corcept from Gilead Sciences Inc., where he most recently served as Senior Vice President and Global Head of Medical Affairs. He will report to Joseph K. Belanoff, MD, Corcept’s Chief Executive Officer.